Invenomic Capital Management’s RE/MAX Holdings RMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-195,990
Closed -$1.13M 154
2026
Q1
$1.13M Sell
195,990
-10,983
-5% -$76K 0.05% 141
2025
Q4
$1.57M Sell
206,973
-4,704
-2% -$38.2K 0.07% 137
2025
Q3
$2M Sell
211,677
-11,314
-5% -$99.9K 0.1% 133
2025
Q2
$1.82M Buy
222,991
+47,588
+27% +$369K 0.1% 139
2025
Q1
$1.47M Buy
+175,403
New +$1.67M 0.07% 158

Other funds holding RMAX

Invenomic Capital Management's RMAX Position: Q2 2026 in Review

Invenomic Capital Management sold out of RE/MAX Holdings (RMAX) in Q2 2026, closing a stake of 195,990 shares — an estimated $1.13M sold.

Invenomic Capital Management first reported a position in RMAX in Q1 2025 and held it in 5 quarters. The position peaked at $2M in Q3 2025. 124 funds tracked by Wall St. Rank hold RMAX as of Q2 2026.

  • Invenomic Capital Management reported no remaining RE/MAX Holdings position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 195,990 RE/MAX Holdings shares in Q2 2026, an estimated $1.13M.
  • Invenomic Capital Management first reported a position in RE/MAX Holdings in Q1 2025 and held it in 5 quarters.
  • Invenomic Capital Management's RE/MAX Holdings position peaked at $2M in Q3 2025.
  • 124 funds tracked by Wall St. Rank held RE/MAX Holdings as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.